Leadership (Bio-Tech) breakout; Good sign for broad market

Below looks at the Bio-Tech ETF XBI since 2012. The chart reflects that over the past 5-years the S&P had done very well, as it is up 70%. Over the same time frame XBI is up 160%, gaining more than 100% more than the broad markets